» Articles » PMID: 18533059

Associations of C-reactive Protein and Interleukin-6 with Cognitive Symptoms of Depression: 12-year Follow-up of the Whitehall II Study

Overview
Journal Psychol Med
Specialty Psychology
Date 2008 Jun 6
PMID 18533059
Citations 230
Authors
Affiliations
Soon will be listed here.
Abstract

Background: A lack of longitudinal studies has made it difficult to establish the direction of associations between circulating concentrations of low-grade chronic inflammatory markers, such as C-reactive protein and interleukin-6, and cognitive symptoms of depression. The present study sought to assess whether C-reactive protein and interleukin-6 predict cognitive symptoms of depression or whether these symptoms predict inflammatory markers.

Method: In a prospective occupational cohort study of British white-collar civil servants (the Whitehall II study), serum C-reactive protein, interleukin-6 and cognitive symptoms of depression were measured at baseline in 1991-1993 and at follow-up in 2002-2004, an average follow-up of 11.8 years. Symptoms of depression were measured with four items describing cognitive symptoms of depression from the General Health Questionnaire. The number of participants varied between 3339 and 3070 (mean age 50 years, 30% women) depending on the analysis.

Results: Baseline C-reactive protein (beta=0.046, p=0.004) and interleukin-6 (beta=0.046, p=0.005) predicted cognitive symptoms of depression at follow-up, while baseline symptoms of depression did not predict inflammatory markers at follow-up. After full adjustment for sociodemographic, behavioural and biological risk factors, health conditions, medication use and baseline cognitive systems of depression, baseline C-reactive protein (beta=0.038, p=0.036) and interleukin-6 (beta=0.041, p=0.018) remained predictive of cognitive symptoms of depression at follow-up.

Conclusions: These findings suggest that inflammation precedes depression at least with regard to the cognitive symptoms of depression.

Citing Articles

The effect of MIND diet on sleep status, mental health, and serum level of BDNF in overweight/obese diabetic women with insomnia: a randomized controlled trial.

Golmohammadi M, Attari V, Salimi Y, Saed L, Nachvak S, Samadi M Sci Rep. 2025; 15(1):8237.

PMID: 40065021 PMC: 11893750. DOI: 10.1038/s41598-025-91389-y.


Joint association of sleep onset time and sleep duration with depression in patients with chronic kidney disease: Insights from the NHANES 2015-2020.

He K, Guo S, Zhu J, Wang Z, Chen S, Luo J Prev Med Rep. 2025; 51:103006.

PMID: 40040931 PMC: 11876893. DOI: 10.1016/j.pmedr.2025.103006.


Key Taxa of the Gut Microbiome Associated with the Relationship Between Environmental Sensitivity and Inflammation-Related Biomarkers.

Takasugi S, Iimura S, Yasuda M, Saito Y, Morifuji M Microorganisms. 2025; 13(1).

PMID: 39858953 PMC: 11767568. DOI: 10.3390/microorganisms13010185.


Functional resting state connectivity is differentially associated with IL-6 and TNF-α in depression and in healthy controls.

Schmitz C, Sammer G, Neumann E, Blecker C, Grunder G, Adolphi H Sci Rep. 2025; 15(1):1769.

PMID: 39800770 PMC: 11725594. DOI: 10.1038/s41598-025-85514-0.


Neohesperidin Improves Depressive-Like Behavior Induced by Chronic Unpredictable Mild Stress in Mice.

Luo L, Liu W, Dong L, Wang S, Wang Q, Jiang Y Neurochem Res. 2025; 50(1):69.

PMID: 39751909 DOI: 10.1007/s11064-024-04323-5.


References
1.
Stansfeld S, Marmot M . Social class and minor psychiatric disorder in British Civil Servants: a validated screening survey using the General Health Questionnaire. Psychol Med. 1992; 22(3):739-49. DOI: 10.1017/s0033291700038186. View

2.
Liukkonen T, Silvennoinen-Kassinen S, Jokelainen J, Rasanen P, Leinonen M, Benno Meyer-Rochow V . The association between C-reactive protein levels and depression: Results from the northern Finland 1966 birth cohort study. Biol Psychiatry. 2006; 60(8):825-30. DOI: 10.1016/j.biopsych.2006.02.016. View

3.
Danesh J, Wheeler J, Hirschfield G, Eda S, Eiriksdottir G, Rumley A . C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med. 2004; 350(14):1387-97. DOI: 10.1056/NEJMoa032804. View

4.
Wichers M, Maes M . The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. Int J Neuropsychopharmacol. 2002; 5(4):375-88. DOI: 10.1017/S1461145702003103. View

5.
Carney R, Freedland K, Miller G, Jaffe A . Depression as a risk factor for cardiac mortality and morbidity: a review of potential mechanisms. J Psychosom Res. 2002; 53(4):897-902. DOI: 10.1016/s0022-3999(02)00311-2. View